Contribution of multidrug resistance protein MRP5 in control of cyclic guanosine 5′-monophosphate intracellular signaling in anterior pituitary cells

Endocrinology

Volumn 147, Issue 7, 2006, Pages 3435-3445

  Andric, Silvana A ^a,b   Kostic, Tatjana S ^a,b   Stojilkovic, Stanko S ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYCLIC GMP; CYCLIC NUCLEOTIDE; FORSKOLIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 8; PROBENECID; PROGESTERONE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; FEMALE; HYPOPHYSIS CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

EID: 33745172184     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0091     Document Type: Article

References (58)

1. McKnight GS 1991 Cyclic AMP second messenger systems. Curr Opin Cell Biol 3:213-217
2. Komuuro M, Shioda T 1981 Cytochemical localization of adenylate cyclase activity in the rat anterior pituitary. Cell Tissue Res 218:103-111
3. Paulssen RH, Johansen PW, Gordeladze JO, Nymoen O, Paulssen EJ, Gautvik KM 1994 Cell-specific expression and function of adenylyl cyclases in rat pituitary tumour cell lines. Eur J Biochem 222:97-103
4. Antoni FA, Barnard RJ, Shipston MJ, Smith SM, Simpson J, Paterson JM 1995 Calcineurin feedback inhibition of agonist-evoked cAMP formation. J Biol Chem 270:28055-28061
5. Antoni FA, Sosunov AA, Haunso A, Paterson JM, Simpson J 2003 Short-term plasticity of cyclic adenosine 3′,5′-monophosphate signaling in anterior pituitary corticotrope cells: the role of adenylyl cyclase isotypes. Mol Endocrinol 17:692-703
6. Cooper DM, Mons N, Karpen JW 1995 Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374:421-424
7. Pyriochou A, Papapetropoulos A 2005 Soluble guanylyl cyclase: more secrets revealed. Cell Signal 17:407-413
8. Kostic TS, Andric SA, Stojilkovic SS 2001 Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells. Mol Endocrinol 15:1010-1022
9. Wolff DJ, Datto GA 1992 Identification and characterization of a calmodul-independent nitric oxide synthase from GH3 pituitary cells. Biochem J 285:201-206
10. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hokfelt T 1993 Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 90:11292-11296
11. Ohta K, Hirata Y, Imai T, Marumo F 1993 Interleukin-1β induces nitric oxide production by a mouse pituitary tumour cell line (AtT20/D16). J Endocrinol 138:429-435
12. Vankelecom H, Denef C 1997 Paracrine communication in the anterior pituitary as studied in reaggregate cell cultures. Microsc Res Tech 39:150-156
13. Garrel G, Lerrant Y, Siriostis C, Berault A, Magre S, Bouchaud C, Counis R 1998 Evidence that gonadotropin-releasing hormone stimulates gene expression and levels of active nitric oxide synthase type I in pituitary gonadotrophs, a process altered by desensitization and, indirectly, by gonadal steroids. Endocrinology 139:2163-2170
14. Lozach A, Garrel G, Lerrant Y, Berault A, Counis R 1998 GnRH-dependent up-regulation of nitric oxide synthase I level in pituitary gonadotrophs mediates cGMP elevation during rat proestrus. Mol Cell Endocrinol 143:43-51
15. Andric SA, Kostic TS, Tomic M, Koshimizu T, Stojilkovic SS 2001 Dependence of soluble guanylyl cyclase activity on calcium signaling in pituitary cells. J Biol Chem 276:844-849
16. Kostic TS, Andric SA, Stojilkovic SS 2004 Receptor-controlled phosphorylation of α1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5′-monophosphate production in pituitary cells. Mol Endocrinol 18:458-470
17. Conti M 2000 Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Mol Endocrinol 14:1317-1327
18. Mehats C, Andersen CB, Filopanti M, Jin SL, Conti M 2002 Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab 13:29-35
19. Persani L, Borgato S, Lania A, Filopanti M, Mantovani G, Conti M, Spada A 2001 Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gsα mutations. J Clin Endocrinol Metab 86:3795-3800
20. Ang KL, Antoni FA 2002 Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation. J Neurochem 81:422-433
21. Beavo JA 1995 Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748
22. Butcher RW, Robison GA, Hardman JG, Sutherland EW 1968 The role of cyclic AMP in hormone actions. Adv Enzyme Regul 6:357-389
23. Kruh GD, Belinsky MG 2003 The MRP family of drug efflux pumps. Oncogene 22:7537-7552
24. Sager G 2004 Cyclic GMP transporters. Neurochem Int 45:865-873
25. Bankir L, Ahloulay M, Devreotes PN, Parent CA 2002 Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved? Am J Physiol Renal Physiol 282:F376-F392
26. Soderling SH, Beavo JA 2000 Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 12:174-179
27. Jedlitschky G, Burchell B, Keppler D 2000 The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem 275:30069-30074
28. Chen ZS, Lee K, Kruh GD 2001 Transport of cyclic nucleotides and estradiol 17-β-d-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem 276:33747-33754
29. Lai L, Tan TM 2002 Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J 361:497-503
30. Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG, Kruh GD 2003 MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine. J Biol Chem 278:29509-29514
31. Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, Borst P 2003 Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 278:17664-17671
32. Andric SA, Gonzalez-Iglesias AE, Van Goor F, Tomic M, Stojilkovic SS 2003 Nitric oxide inhibits prolactin secretion in pituitary cells downstream of voltage-gated calcium influx. Endocrinology 144:2912-2921
33. Telfer JF, Itoh H, Thomson AJ, Norman JE, Nakao K, Campa JS, Poston L, Tribe RM, Magness RR 2001 Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term. J Clin Endocrinol Metab 86:5934-5943
34. Xu HL, Gavrilyuk V, Wolde HM, Baughman VL, Pelligrino DA 2004 Regulation of rat pial arteriolar smooth muscle relaxation in vivo through multidrug resistance protein 5-mediated cGMP efflux. Am J Physiol Heart Circ Physiol 286:H2020-H2027
35. Orlov SN, Maksimova NV 1999 Efflux of cyclic adenosine monophosphate from cells: mechanisms and physiological implications. Biochemistry (Mosc) 64:127-135
36. Broadus AE, Kaminsky NI, Northcutt RC, Hardman JG, Sutherland EW, Liddle GW 1970 Effects of glucagon on adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine. J Clin Invest 49:2237-2245
37. Kaminsky NI, Broadus AE, Hardman JG, Jones Jr DJ, Ball JH, Sutherland EW, Liddle GW 1970 Effects of parathyroid hormone on plasma and urinary adenosine 3′,5′-monophosphate in man. J Clin Invest 49:2387-2395
38. Kuster J, Zapf J, Jakob A 1973 Effects of hormones on cyclic AMP release in perfused rat livers. FEBS Lett 32:73-77
39. Zumstein P, Zapf J, Froesch ER 1974 Effects of hormones on cyclic AMP release from rat adipose tissue in vitro. FEBS Lett 49:65-69
40. O'Dea RF, Gagnon C, Zatz M 1978 Regulation of guanosine 3′,5′ cyclic monophosphate in the rat pineal and posterior pituitary glands. J Neurochem 31:733-738
41. de Koning HP, Jenks BG, Huchede B, Roubos EW 1992 Dynamics of cyclic-AMP efflux in relation to α-MSH secretion from melanotrope cells of Xenopus laevis. Life Sci 51:1667-1673
42. Lania A, Gil-del-Alamo P, Saccomanno K, Persani L, Faglia G, Spada A 1995 Mechanism of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in human nonfunctioning pituitary tumors. J Neuroendocrinol 7:695-702
43. Van Duijn B, Vogelzang SA, Ypey DL, Van der Molen LG, Van Haastert PJ 1990 Normal chemotaxis in Dictyostelium discoideum cells with a depolarized plasma membrane potential. J Cell Sci 95:177-183
44. Schmitt A, Nebreda AR 2002 Inhibition of Xenopus oocyte meiotic maturation by catalytically inactive protein kinase A. Proc Natl Acad Sci USA 99:4361-4366
45. Jackson EK, Dubey RK 2001 Role of the extracellular cAMP-adenosine pathway in renal physiology. Am J Physiol Renal Physiol 281:F597-F612
46. Poulopoulou C, Nowak LM 1998 Extracellular 3′,5′ cyclic guanosine monophosphate inhibits kainate-activated responses in cultured mouse cerebellar neurons. J Pharmacol Exp Ther 286:99-109
47. Touyz RM, Picard S, Schiffrin EL, Deschepper CF 1997 Cyclic GMP inhibits a pharmacologically distinct Na+/H+ exchanger variant in cultured rat astrocytes via an extracellular site of action. J Neurochem 68:1451-1461
48. Barber R, Butcher RW 1981 The quantitative relationship between intracellular concentration and egress of cyclic AMP from cultured cells. Mol Pharmacol 19:38-43
49. Fehr TF, Dickinson ES, Goldman SJ, Slakey LL 1990 Cyclic AMP efflux is regulated by occupancy of the adenosine receptor in pig aortic smooth muscle cells. J Biol Chem 265:10974-10980
50. Ahlstrom M, Lamberg-Allardt C 1999 Regulation of adenosine 3′,5′-cyclic monophosphate (cAMP) accumulation in UMR-106 osteoblast-like cells: role of cAMP-phosphodiesterase and cAMP efflux. Biochem Pharmacol 58:1335-1340
51. Brunton LL, Mayer SE 1979 Extrusion of cyclic AMP from pigeon erythrocytes. J Biol Chem 254:9714-9720
52. Schultz C, Vaskinn S, Kildalsen H, Sager G 1998 Cyclic AMP stimulates the cyclic GMP egression pump in human erythrocytes: effects of probenecid, verapamil, progesterone, theophylline, IBMX, forskolin, and cyclic AMP on cyclic GMP uptake and association to inside-out vesicles. Biochemistry 37:1161-1166
53. Antoni FA 2000 Molecular diversity of cyclic AMP signalling. Front Neuroendocrinol 21:103-132
54. Kostic TS, Tomic M, Andric SA, Stojilkovic SS 2002 Calcium-independent and cAMP-dependent modulation of soluble guanylyl cyclase activity by G protein-coupled receptors in pituitary cells. J Biol Chem 277:16412-16418
55. Tomic M, Koshimizu T, Yuan D, Andric SA, Zivadinovic D, Stojilkovic SS 1999 Characterization of a plasma membrane calcium oscillator in rat pituitary somatotrophs. J Biol Chem 274:35693-35702
56. Van Goor F, Zivadinovic D, Stojilkovic SS 2001 Differential expression of ionic channels in rat anterior pituitary cells. Mol Endocrinol 15:1222-1236
57. Klyachko VA, Ahern GP, Jackson MB 2001 cGMP-mediated facilitation in nerve terminals by enhancement of the spike after hyperpolarization. Neuron 31:1015-1025
58. Adachi M, Reid G, Schuetz JD 2002 Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5. Adv Drug Deliv Rev 54:1333-1342